.

Horizon Pharma reported $787.85M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 11288M 2467M
Aerie Pharmaceuticals AERI:US $ 51.45M 12.03M
ALKERMES ALKS:US 310.68M 5.55M
Amgen AMGN:US $ 4.42B 680M
AstraZeneca AZN:LN 840.42B 39.99B
Bristol Myers Squibb BMY:US $ 9.3B 202M
Cara Therapeutics CARA:US $ 27.48M 5.23M
Coherus Biosciences CHRS:US $ 104.16M 43.1M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Horizon Pharma HZNP:US $ 787.85M 96.93M
JAZZ PHA JAZZ:US $ 847.33M 121.16M
Merk MRK:US $ 9666M 666M
Novartis NOVN:VX 10.86B 895M
Pacira Pharmaceuticals PCRX:US $ 138.18M 2.42M
Perrigo Ordinary Shares PRGO:US $ 1137.9M 85.1M
Pfizer PFE:US $ 15640M 148M
Prestige Brands PBH:US $ 190.04M 534K
Revance Therapeutics RVNC:US $ 86.21M 1.27M
Supernus Pharmaceuticals SUPN:US $ 158.7M 8.17M
Takeda 4502:JP 821.95B 52.96B
Teva Pharmaceutical Industries TEVA:US 4.74B 361M
Valeant Pharmaceuticals VRX:CN C$ 2.18B 546.23M
Xeris Pharmaceuticals Inc XERS:US $ 44.22M 6.92M
Zoetis ZTS:US $ 1.38B 123M